Michael E. Hart

MICHAEL E. HART is President and Chief Executive Officer of Allos
Therapeutics, inc. He joined the company in 1999 and was promoted
to President and Chief Executive Officer in December 2001 and to
the Board of Directors in April 2002. Prior to his promotion, he
was Chief Financial Officer and Senior Vice President of
Operations. From 1998 to 1999, Mr. Hart served as Chairman of the
Management Committee of NeXstar Pharmaceuticals, Inc., and led
the sale of the company to Gilead Sciences in July 1999. From
1990 to 1998, Mr. Hart served as Vice President, Chief Financial
Officer of NeXstar Pharmaceuticals Inc. and its predecessor
Vestar, Inc. During his tenure, Mr. Hart was instrumental in
building an international organization that supported $120
million in product revenues in over 30 countries around the
world. During this period he also helped successfully guide
NeXstar through two company acquisitions and several product
approvals. Between 1976-1990, Mr. Hart held various financial
positions with several high technology companies in the Silicon
Valley. Mr. Hart received his MBA from California State
University, Fresno, and his undergraduate degrees in Business
Economics and Geography from the University of California, Santa